Asymptomatic Renal Calculi in Recurrent Urinary Tract Infections
- Conditions
- Urinary Tract InfectionsKidney Stone
- Interventions
- Other: None - observational
- Registration Number
- NCT04495699
- Lead Sponsor
- Vanderbilt University Medical Center
- Brief Summary
This study will assess patients who have recurrent urinary tract infections and kidney stones which are not blocking the kidney or causing other problems. Currently, we don't know if taking out these stones will improve recurrent urinary tract infections or not. Patients will make a decision with their surgeon about removing or monitoring their stone(s). Whether or not their infections continue with surgery or monitoring will be noted, and this information may help to inform future treatment decisions. The purpose of this study is to assess if treatment of these asymptomatic stones affects the rate of recurrent urinary tract infections.
- Detailed Description
Urinary tract infections (UTIs) are common and have a large burden of disease at the population level. This study will assess the effectiveness of removing kidney stones in patients who have recurrent UTIs.
The role of upper urinary tract calculi in UTIs is not well understood. Although there is some evidence that some metabolic stones, such as calcium oxalate, can harbor bacteria, it is not known if this is clinically significant or if these contribute to clinical infections.
This study aims to advance the level of evidence in the treatment of non-obstructing urolithiasis in the context of recurrent UTIs.
The aim of this study is to:
1. Assess the effects of treatment of non-obstructing upper urinary tract calculi on recurrent UTIs in the first prospective observational trial in this area
Patients who meet inclusion criteria will make a decision about treating their asymptomatic stones or not with their surgeon as per usual clinical care. The primary outcome will be the rate of recurrent urinary tract infections for patients, comparing patients who did and did not have their stones treated.
Patient data is securely stored in de-identified fashion in REDCAP database, following all the secure protocols of the institutions involved. The recruitment goal is 80 patients based on power calculations to detect the effect size. Statistical analysis will be performed between the two groups, with t-test used for normally distributed numerical data and fisher's exact or chi-square tests for categorical data.
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 80
Not provided
- age < 18 years
- pregnancy
- hydronephrosis or evidence of obstruction
- presence of a foreign body in urinary tract (e.g. Foley, ureteral stent, nephrostomy tube) at the time of UTI diagnosis
- concurrent bladder calculi
- Urinary diversion or previous surgery involving segments of bowel interposed into the urinary tract (ileal conduit, ileal ureter etc.)
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Stone treated None - observational Patients who elect to have intervention of their asymptomatic stones as part of usual care will be followed. Note that there is no randomization, the decision to treat or not treat a stone is made in the usual clinical fashion by the patient in consultation with their surgeon.
- Primary Outcome Measures
Name Time Method Recurrent urinary tract infections 12 months • Number of UTIs, defined as positive urine culture (\>10\^5 CFU/mL of a specific organism) with symptoms. If having had surgical intervention for the stones, we will count a UTI during \>30days and \<1year after intervention so that it is not attributed to the intervention
- Secondary Outcome Measures
Name Time Method Stone analysis correlation with rUTI 12 months Correlation between primary outcome and stone analysis
Correlation of selected demographic factors with rUTI 12 months Correlation between baseline demographic parameters and recurrent UTIs (including include age, sex, bacteria type, previous sequelae from UTIs, previous sequelae from stones, comorbidities including diabetes mellitus, obesity, hypertension, and immunosuppression, creatinine, total stone burden, location of stones, stone composition, stone culture, post-intervention stone free rate, and 24-h urine parameters if available)
Number free from any UTI 12 months Number of patients free from any UTI at one year, as defined above
Pyelonephritis/urosepsis up to 12 months Incidence of pyelonephritis/urosepsis
Stone free vs not stone free correlation with rUTI 12 months Correlation between stone free status after intervention and recurrent UTI
Crossover from observation to intervention 12 months Patients on observation and decide to seek treatment after enrollment
Time to first UTI up to 12 months Time from first visit to first UTI, defined as above
Number free from recurrent UTIs 12 months Number patients free of recurrent UTIs at 1 year, defined as 3 positive urine cultures (\>105 CFU/mL of a specific organism) with symptoms in 1 year, or 2 in 6 months. If having had surgical intervention for the stones, we will count a UTI during \>30days and \<1year after intervention so that it is not attributed to the intervention
Incidence of complications from intervention within 30 days 30 days Clavien-Dindo complications, ER visits, readmissions, infections within 30 days, non-elective repeat interventions (eg for obstructing fragments)
Incidence of further intervention for stones 12 months any further stone interventions required
Trial Locations
- Locations (6)
University of California San Diego
🇺🇸San Diego, California, United States
Vancouver General Hospital/University of British Columbia
🇨🇦Vancouver, British Columbia, Canada
Mayo Clinic Arizona
🇺🇸Phoenix, Arizona, United States
Vanderbilt University Medical Center
🇺🇸Nashville, Tennessee, United States
Massachusetts General Hospital
🇺🇸Boston, Massachusetts, United States
Columbia University
🇺🇸New York, New York, United States